Catalyst
Slingshot members are tracking this event:
Neurocrine (NBIX) Expects Phase 2 T-Force GREEN Data in Q2 Evaluating Ingrezza in Pediatric Patients With Tourette Syndrome
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NBIX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 23, 2017
Occurred Source:
http://phoenix.corporate-ir.net/phoenix.zhtml?c=68817&p=irol-newsArticle&ID=2276016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, T-force Green, Ingrezza, Pediatric Patients, Tourette Syndrome
